As of 3:59pm ET
| -0.11 / -2.05%|
The 7 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 26.00 and a low estimate of 10.00. The median estimate represents a +128.14% increase from the last price of 5.26.
The current consensus among 7 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.